Microdosing & Medications: A Pharmacists Guide to Safety

Over 1 in 5 adults are receiving treatment for their mental health, including taking prescription medication or receiving therapy, yet many are left asking: Why am I not feeling better?

Research shows that approximately 50 percent of people with depression do not fully respond to first-line antidepressants, leading more people to explore alternatives like microdosing psychedelics in search of a new solution and a potentially different relationship to their mental health. 

Emerging data reflects this shift. A recent report found that an estimated 8.4 million American adults have microdosed psilocybin, with mental health as the primary motivation. However, the efficacy of microdosing from clinical trials shows it may not significantly improve mood, cognition, other behavioral and subjective measures, or even support specific conditions like ADHD compared to placebo.

With the increase in microdosing, the uncertainty around its clinical effectiveness, and as it exists in a legal gray area often with limited clinical guidance, many people are left to navigate the risks on their own – especially when layered onto existing medications and health conditions.

So what does it actually mean to microdose safely when medications are part of the picture?